The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. This meeting addresses the high-level of need for clinical education in a field where all aspects of care are fundamentally different from traditional therapies.
Why Should you Attend this Meeting?
CONNECT: Meet faculty members and fellow attendees from around the world in both formal and informal networking events.
DISCOVER: Attend education and science sessions that explore pioneering clinical and translational research and breakthroughs in immuno-oncology and its implications for patient care.
ENGAGE: Ask expert faculty your most pressing questions in extended Question and Answer panels. Visit the exhibits to expand your understanding of the most advanced therapies, products, and upcoming research.
GET CREDIT: Earn CME credit and MOC points from ABIM and ABAI for attending the Symposium.
Mario Sznol, MD* – Yale Cancer Center (SITC President)
Lawrence Fong, MD* – University of California San Francisco
Hussein Tawbi, MD, PhD* – MD Anderson Cancer Center
Michael Sadelain, MD, PhD – Memorial Sloan Kettering Cancer Center
Madhav V. Dhodapkar, MBBS* – Emory University
Jennifer A. Wargo, MD, MMSc* – MD Anderson Cancer CenterASCO Organizers
Stephen Gottschalk, MD* – St. Jude Children's Research Hospital
Kunle Odunsi, MD, PhD* – Roswell Park Comprehensive Cancer Center
Robert Dreicer, MD, MS, MACP, FASCO – University of Virginia Cancer Center
Dung T. Le, MD – Johns Hopkins Univeristy
Allison Betof-Warner, MD, PhD – Memorial Sloan Kettering Cancer Center
Edward B. Garon, MD, MS* – University of California Los Angeles*Denotes SITC MemberTo find out more information, please click here.